Genetic Deletions in AML and MDS

Best Practice and Research in Clinical Haematology - United Kingdom
doi 10.1016/j.beha.2010.09.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

From MDS/AML to iPSC and Back Again

Science Translational Medicine
Medicine
2017English

Molecular Characterization of Chromosome 7 in AML and MDS Patients

African Journal of Health Sciences
2008English

Physicians Poster Session: Acute Leukemia and Secondary AML/MDS

Bone Marrow Transplantation
TransplantationHematology
2003English

Paclitaxel Induced MDS and AML: A Case Report and Literature Review

Case Reports in Oncological Medicine
Oncology
2016English

WT1 Vaccination in AML and MDS: A Pilot Trial With Synthetic Analog Peptides

American Journal of Hematology
Hematology
2015English

alloSCT Bei AML Oder MDS: Dosisreduzierte Konditionierung Erhöht Die Rezidivrate

Im Focus Onkologie
2017English

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Integrated Bioinformatic Analysis of Microarray Data Reveals Shared Gene Signature Between MDS and AML

Oncology Letters
Cancer ResearchOncology
2018English

Translocation T(1;3)(p36;p21) and Other Aberrations in a Case of AML Secondary to MDS

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy